• Publications
  • Influence
Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease
To explore the clinical significance of restless legs syndrome (RLS) in Parkinson's disease (PD) and the causal relationship between these two disorders, we made a comparison of both the prevalenceExpand
  • 138
  • 16
Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory.
BACKGROUND Various Japanese versions of the Epworth Sleepiness Scale (ESS) have been used, but none was developed via standard procedures. Here we report on the construction and testing of theExpand
  • 170
  • 14
Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patients.
OBJECTIVE We evaluated the usefulness of the REM sleep behavior disorder (RBD) screening questionnaire (RBDSQ) among patients with Parkinson's disease (PD). METHODS Forty-five patients with PD wereExpand
  • 109
  • 13
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the
A Task Force was established by the International Restless Legs Syndrome Study Group (IRLSSG) in conjunction with the European Restless Legs Syndrome Study Group (EURLSSG) and the RLS FoundationExpand
  • 127
  • 10
  • PDF
Prevalence of restless legs syndrome in a rural community in Japan
To assess the prevalence and clinical significance of restless legs syndrome (RLS) in a Japanese population, we carried out a community‐based survey in a rural area of Japan. We sent questionnairesExpand
  • 123
  • 9
A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia
Previous meta-analyses have shown the effectiveness of cognitive behavioral therapy for insomnia (CBT-I). However, conclusive information about therapeutic effects (especially during follow-up),Expand
  • 210
  • 8
Expanding the clinical phenotype of SNCA duplication carriers
SNCA duplication is a recognized cause of familial Parkinson's disease (PD). We aimed to explore the genetic and clinical variability in the disease manifestation. Molecular characterization wasExpand
  • 115
  • 8
Development and validation of the Japanese version of the Athens Insomnia Scale
The aim of this study was to develop and validate a Japanese version of the Athens Insomnia Scale (AIS‐J).
  • 65
  • 8
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement
OBJECTIVES We aimed to provide a consensus statement by the International Rapid Eye Movement Sleep Behavior Disorder Study Group (IRBD-SG) on devising controlled active treatment studies in rapid eyeExpand
  • 130
  • 7
NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis.
AIM To investigate an association between N-acetyltransferase 2 (NAT2)-haplotypes/diplotypes and adverse effects in Japanese pulmonary tuberculosis patients. METHODS We studied 100 patients withExpand
  • 63
  • 6